Figure 5.
Response of T cell subsets before and after cryopreservation. Human PBMCs were incubated with CD3/CD28 agonist TransAct. Non-specific binding was compared between immune cell subsets at fresh and day 70 (A). Anti-puromycin GeoMFI for T cell subsets in unactivated and activated conditions was compared at fresh (B). Comparing unactivated (UA-Co) and activated (P-Co) samples, increase in protein translation upon activation is shown for CD4+ Naïve (C) and TCM (D) T cells, and CD8+ Naïve (E) and TEM (F) T cells. (*P < .05, **P < .01, Friedman Test with Dunn’s multiple comparisons test comparing Days 15, 35 and 70 to fresh only, n=5. Data presented in (B) are descriptive only).

Response of T cell subsets before and after cryopreservation. Human PBMCs were incubated with CD3/CD28 agonist TransAct. Non-specific binding was compared between immune cell subsets at fresh and day 70 (A). Anti-puromycin GeoMFI for T cell subsets in unactivated and activated conditions was compared at fresh (B). Comparing unactivated (UA-Co) and activated (P-Co) samples, increase in protein translation upon activation is shown for CD4+ Naïve (C) and TCM (D) T cells, and CD8+ Naïve (E) and TEM (F) T cells. (*P<.05, **P<.01, Friedman Test with Dunn’s multiple comparisons test comparing Days 15, 35 and 70 to fresh only, n=5. Data presented in (B) are descriptive only).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close